Skip to main content
SpringerLink
Log in

Uncommon Tumors and Mimickers of Cancer

  • Chapter
  • First Online:
Challenging Cases in Gynecologic Surgical Pathology

  • 70 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferry JA, Scully RE. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol. 1990;14(12):1100–11.

    Article  CAS  PubMed  Google Scholar 

  2. Roy SF, Wong J, Latour M, Reichetzer B, Rahimi K. Ductal-type mesonephric duct/remnant hyperplasia: distinguished from lobular or diffuse mesonephric hyperplasia by the presence of a myoepithelial cell layer and micropapillary tufting. Pathology. 2022;54(3):378–81.

    Article  CAS  PubMed  Google Scholar 

  3. Howitt BE, Nucci MR. Mesonephric proliferations of the female genital tract. Pathology. 2018;50(2):141–50.

    Article  PubMed  Google Scholar 

  4. Mirkovic J, Schoolmeester JK, Campbell F, Miron A, Nucci MR, Howitt BE. Cervical mesonephric hyperplasia lacks KRAS/NRAS mutations. Histopathology. 2017;71(6):1003–5.

    Article  PubMed  Google Scholar 

  5. Clement PB, Young RH. Endocervicosis of the urinary bladder. A report of six cases of a benign Müllerian lesion that may mimic adenocarcinoma. Am J Surg Pathol. 1992;16(6):533–42.

    Article  CAS  PubMed  Google Scholar 

  6. Young RH, Clement PB. Endocervicosis involving the uterine cervix: a report of four cases of a benign process that may be confused with deeply invasive endocervical adenocarcinoma. Int J Gynecol Pathol. 2000;19(4):322–8.

    Article  CAS  PubMed  Google Scholar 

  7. Mukonoweshuro P, McCluggage WG. Endocervicosis involving axillary lymph nodes: first case report. Int J Gynecol Pathol. 2014;33(6):620–3.

    Article  PubMed  Google Scholar 

  8. Jebakumar D, Asirvatham JR. Endocervicosis in an intramammary lymph node. Int J Surg Pathol. 2022;30(7):784–8.

    Article  PubMed  Google Scholar 

  9. Nakaguro M, Tsuzuki T, Shimada S, Taki T, Tsuchiyama M, Kitamura A, et al. Adenocarcinoma arising in urinary bladder endocervicosis. Pathol Int. 2016;66(2):108–13.

    Article  PubMed  Google Scholar 

  10. Roma AA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, Chanona-Vilchis JG, et al. Invasive endocervical adenocarcinoma: a new pattern-based classification system with important clinical significance. Am J Surg Pathol. 2015;39(5):667–72.

    Article  PubMed  Google Scholar 

  11. Stolnicu S, Hoang L, Soslow RA. Recent advances in invasive adenocarcinoma of the cervix. Virchows Arch. 2019;475(5):537–49.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri” [Int J Gynecol Obstet. 145(2019):129–35]. Int J Gynaecol Obstet. 2019;147(2):279–80.

    Google Scholar 

  13. Alvarado-Cabrero I, Parra-Herran C, Stolnicu S, Roma A, Oliva E, Malpica A. The silva pattern-based classification for HPV-associated invasive endocervical adenocarcinoma and the distinction between in situ and invasive adenocarcinoma: relevant issues and recommendations from the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2021;40(Suppl 1):S48–s65.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Roma AA, Mistretta TA, Diaz De Vivar A, Park KJ, Alvarado-Cabrero I, Rasty G, et al. New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome. Gynecol Oncol. 2016;141(1):36–42.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Mikami Y. Gastric-type mucinous carcinoma of the cervix and its precursors—historical overview. Histopathology. 2020;76(1):102–11.

    Article  PubMed  Google Scholar 

  16. Nucci MR, Clement PB, Young RH. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol. 1999;23(8):886–91.

    Article  CAS  PubMed  Google Scholar 

  17. Mikami Y, Hata S, Fujiwara K, Imajo Y, Kohno I, Manabe T. Florid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia: worrisome benign mimic of “adenoma malignum”. Gynecol Oncol. 1999;74(3):504–11.

    Article  CAS  PubMed  Google Scholar 

  18. Talia KL, Stewart CJR, Howitt BE, Nucci MR, McCluggage WG. HPV-negative gastric type adenocarcinoma in situ of the cervix: a spectrum of rare lesions exhibiting gastric and intestinal differentiation. Am J Surg Pathol. 2017;41(8):1023–33.

    Article  PubMed  Google Scholar 

  19. Ishii K, Hosaka N, Toki T, Momose M, Hidaka E, Tsuchiya S, et al. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch. 1998;432(4):315–22.

    Article  CAS  PubMed  Google Scholar 

  20. Wong RW, Ralte A, Grondin K, Talia KL, McCluggage WG. Endometrial gastric (gastrointestinal)-type mucinous lesions: report of a series illustrating the spectrum of benign and malignant lesions. Am J Surg Pathol. 2020;44(3):406–19.

    Article  PubMed  Google Scholar 

  21. Lu S, Shen D, Zhao Y, Kang N, Wang X. Primary endocervical gastric-type adenocarcinoma: a clinicopathologic and immunohistochemical analysis of 23 cases. Diagn Pathol. 2019;14(1):72.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mikami Y, Kiyokawa T, Hata S, Fujiwara K, Moriya T, Sasano H, et al. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and ‘adenoma malignum’. Mod Pathol. 2004;17(8):962–72.

    Article  PubMed  Google Scholar 

  23. Kojima A, Mikami Y, Sudo T, Yamaguchi S, Kusanagi Y, Ito M, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol. 2007;31(5):664–72.

    Article  PubMed  Google Scholar 

  24. Karamurzin YS, Kiyokawa T, Parkash V, Jotwani AR, Patel P, Pike MC, et al. Gastric-type endocervical adenocarcinoma: an aggressive tumor with unusual metastatic patterns and poor prognosis. Am J Surg Pathol. 2015;39(11):1449–57.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Garg S, Nagaria TS, Clarke B, Freedman O, Khan Z, Schwock J, et al. Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing. Mod Pathol. 2019;32(12):1823–33.

    Article  CAS  PubMed  Google Scholar 

  26. Chiang S, Cotzia P, Hyman DM, Drilon A, Tap WD, Zhang L, et al. NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma. Am J Surg Pathol. 2018;42(6):791–8.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Mills AM, Karamchandani JR, Vogel H, Longacre TA. Endocervical fibroblastic malignant peripheral nerve sheath tumor (neurofibrosarcoma): report of a novel entity possibly related to endocervical CD34 fibrocytes. Am J Surg Pathol. 2011;35(3):404–12.

    Article  PubMed  Google Scholar 

  28. Hechtman JF, Benayed R, Hyman DM, Drilon A, Zehir A, Frosina D, et al. Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions. Am J Surg Pathol. 2017;41(11):1547–51.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gatalica Z, Xiu J, Swensen J, Vranic S. Molecular characterization of cancers with NTRK gene fusions. Mod Pathol. 2019;32(1):147–53.

    Article  CAS  PubMed  Google Scholar 

  30. Nilforoushan N, Wethington SL, Nonogaki H, Gross J, Vang R, Xing D. NTRK-fusion sarcoma of the uterine cervix: report of 2 cases with comparative clinicopathologic features. Int J Gynecol Pathol. 2022;41(6):642–8.

    Article  PubMed  Google Scholar 

  31. Khotskaya YB, Holla VR, Farago AF, Mills Shaw KR, Meric-Bernstam F, Hong DS. Targeting TRK family proteins in cancer. Pharmacol Ther. 2017;173:58–66.

    Article  CAS  PubMed  Google Scholar 

  32. Shih IM, Kurman RJ. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol. 1998;22(11):1393–403.

    Article  CAS  PubMed  Google Scholar 

  33. Kurman RJ, Shih Ie M. Discovery of a cell: reflections on the checkered history of intermediate trophoblast and update on its nature and pathologic manifestations. Int J Gynecol Pathol. 2014;33(4):339–47.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Palmer JE, Macdonald M, Wells M, Hancock BW, Tidy JA. Epithelioid trophoblastic tumor: a review of the literature. J Reprod Med. 2008;53(7):465–75.

    CAS  PubMed  Google Scholar 

  35. Banet N, Gown AM, Shih Ie M, Kay Li Q, Roden RB, Nucci MR, et al. GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility. Am J Surg Pathol. 2015;39(1):101–8.

    Article  PubMed  PubMed Central  Google Scholar 

  36. McCarthy WA, Paquette C, Gundogan F, Lawrence WD. Comparison of p63 and p40 immunohistochemical stains to distinguish epithelioid trophoblastic tumor from other trophoblastic lesions. Int J Gynecol Pathol. 2018;37(4):401–4.

    Article  PubMed  Google Scholar 

  37. Mao TL, Seidman JD, Kurman RJ, Shih Ie M. Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor—an aid in differential diagnosis. Am J Surg Pathol. 2006;30(9):1105–10.

    Article  PubMed  Google Scholar 

  38. Shih Ie M. Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Ann Diagn Pathol. 2007;11(3):228–34.

    Article  PubMed  Google Scholar 

  39. Kaur B, Short D, Fisher RA, Savage PM, Seckl MJ, Sebire NJ. Atypical placental site nodule (APSN) and association with malignant gestational trophoblastic disease; a clinicopathologic study of 21 cases. Int J Gynecol Pathol. 2015;34(2):152–8.

    Article  PubMed  Google Scholar 

  40. Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155 Suppl 1(Suppl 1):86–93.

    Article  PubMed  Google Scholar 

  41. Lesack D, Wahab I, Gilks CB. Radiation-induced atypia of endocervical epithelium: a histological, immunohistochemical and cytometric study. Int J Gynecol Pathol. 1996;15(3):242–7.

    Article  CAS  PubMed  Google Scholar 

  42. Gupta S, Mukherjee K, Gupta YN, Kumar M. Sequential radiation changes in cytology of vaginal smears in carcinoma of cervix uteri during radiotherapy. Int J Gynaecol Obstet. 1987;25(4):303–8.

    Article  CAS  PubMed  Google Scholar 

  43. Zannoni GF, Vellone VG, Carbone A. Morphological effects of radiochemotherapy on cervical carcinoma: a morphological study of 50 cases of hysterectomy specimens after neoadjuvant treatment. Int J Gynecol Pathol. 2008;27(2):274–81.

    PubMed  Google Scholar 

  44. Saito T, Takehara M, Tanaka R, Lee R, Horie M, Wataba K, et al. Correlation between responsiveness of neoadjuvant chemotherapy and apoptosis-associated proteins for cervical adenocarcinoma. Gynecol Oncol. 2004;92(1):284–92.

    Article  CAS  PubMed  Google Scholar 

  45. Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Ferrandina G, et al. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. Int J Gynecol Cancer. 2014;24(5):916–22.

    Article  PubMed  Google Scholar 

  46. Inzani F, Angelico G, Santoro A, Travaglino A, Insabato L, Raffone A, et al. SATB2 is expressed in neuroendocrine carcinoma of the uterine cervix. Virchows Arch. 2022;480(4):873–7.

    Article  CAS  PubMed  Google Scholar 

  47. Inzani F, Santoro A, Angelico G, Feraco A, Spadola S, Arciuolo D, et al. Neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and immunohistochemical study with focus on novel markers (Sst2-Sst5). Cancers (Basel). 2020;12(5):1211.

    Article  CAS  PubMed  Google Scholar 

  48. Kuji S, Watanabe R, Sato Y, Iwata T, Hirashima Y, Takekuma M, et al. A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: analysis of 37 cases. Gynecol Oncol. 2017;144(2):384–90.

    Article  CAS  PubMed  Google Scholar 

  49. Howitt BE, Kelly P, McCluggage WG. Pathology of neuroendocrine tumours of the female genital tract. Curr Oncol Rep. 2017;19(9):59.

    Article  PubMed  Google Scholar 

  50. McCluggage WG, Kennedy K, Busam KJ. An immunohistochemical study of cervical neuroendocrine carcinomas: neoplasms that are commonly TTF1 positive and which may express CK20 and P63. Am J Surg Pathol. 2010;34(4):525–32.

    Article  PubMed  Google Scholar 

  51. Satoh T, Takei Y, Treilleux I, Devouassoux-Shisheboran M, Ledermann J, Viswanathan AN, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S102–8.

    Article  PubMed  Google Scholar 

  52. WHO Classification of Tumours Editorial Board. Female genital tumours, vol. 4. 5th ed. Lyon: International Agency for Research on Cancer; 2020. WHO Classification of Tumours Series.

    Google Scholar 

  53. Park JJ, Sun D, Quade BJ, Flynn C, Sheets EE, Yang A, et al. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol. 2000;24(10):1414–9.

    Article  CAS  PubMed  Google Scholar 

  54. Onishi J, Sato Y, Sawaguchi A, Yamashita A, Maekawa K, Sameshima H, et al. Stratified mucin-producing intraepithelial lesion with invasive carcinoma: 12 cases with immunohistochemical and ultrastructural findings. Hum Pathol. 2016;55:174–81.

    Article  CAS  PubMed  Google Scholar 

  55. Lastra RR, Park KJ, Schoolmeester JK. Invasive stratified mucin-producing carcinoma and stratified mucin-producing intraepithelial lesion (SMILE): 15 cases presenting a spectrum of cervical neoplasia with description of a distinctive variant of invasive adenocarcinoma. Am J Surg Pathol. 2016;40(2):262–9.

    Article  PubMed  Google Scholar 

  56. Boyle DP, McCluggage WG. Stratified mucin-producing intraepithelial lesion (SMILE): report of a case series with associated pathological findings. Histopathology. 2015;66(5):658–63.

    Article  PubMed  Google Scholar 

  57. Stolnicu S, Talia KL, McCluggage WG. The evolving spectrum of precursor lesions of cervical adenocarcinomas. Adv Anat Pathol. 2020;27(5):278–93.

    Article  PubMed  Google Scholar 

  58. Arslanian E, Singh K, Hansen K, Quddus MR. Benign stratified intraepithelial mucinous proliferation of the uterine cervix: significance of a previously unreported potential mimic of SMILE. Ann Diagn Pathol. 2022;60:152025.

    Article  PubMed  Google Scholar 

  59. Li RF, Gupta M, McCluggage WG, Ronnett BM. Embryonal rhabdomyosarcoma (botryoid type) of the uterine corpus and cervix in adult women: report of a case series and review of the literature. Am J Surg Pathol. 2013;37(3):344–55.

    Article  PubMed  Google Scholar 

  60. Daya DA, Scully RE. Sarcoma botryoides of the uterine cervix in young women: a clinicopathological study of 13 cases. Gynecol Oncol. 1988;29(3):290–304.

    Article  CAS  PubMed  Google Scholar 

  61. de Kock L, Yoon JY, Apellaniz-Ruiz M, Pelletier D, McCluggage WG, Stewart CJR, et al. Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma. Mod Pathol. 2020;33(6):1207–19.

    Article  PubMed  Google Scholar 

  62. Dehner LP, Jarzembowski JA, Hill DA. Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations. Mod Pathol. 2012;25(4):602–14.

    Article  PubMed  Google Scholar 

  63. Kommoss FKF, Stichel D, Mora J, Esteller M, Jones DTW, Pfister SM, et al. Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup. Mod Pathol. 2021;34(8):1558–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Devins KM, Young RH, Ghioni M, Burandt E, Bennett JA, Oliva E. Embryonal rhabdomyosarcoma of the uterine cervix: a clinicopathologic study of 94 cases emphasizing issues in differential diagnosis staging, and prognostic factors. Am J Surg Pathol. 2022;46(11):1477–89.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR, USA

    Ozlen Saglam

Authors
  1. Ozlen Saglam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ozlen Saglam .

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Saglam, O. (2023). Uncommon Tumors and Mimickers of Cancer. In: Challenging Cases in Gynecologic Surgical Pathology. Springer, Cham. https://doi.org/10.1007/978-3-031-51656-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-51656-6_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-51655-9

  • Online ISBN: 978-3-031-51656-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation